1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Plasma Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Human Serum Protein
  • 1.2.3 Plasma-Derived Clotting Factor
  • 1.2.4 Immunoglobulins
  • 1.2.5 High Immunoglobulins
• 1.3 Market by Application
  • 1.3.1 Global Plasma Therapeutics Market Share by Application: 2020 VS 2026
  • 1.3.2 Research Laboratories And Institutions
  • 1.3.3 Hospitals
  • 1.3.4 Stand-Alone Blood Banks
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Plasma Therapeutics Market Perspective (2015-2026)
• 2.2 Global Plasma Therapeutics Growth Trends by Regions
  • 2.2.1 Plasma Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Plasma Therapeutics Historic Market Share by Regions (2015-2020)
  • 2.2.3 Plasma Therapeutics Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Plasma Therapeutics Players by Market Size
  • 3.1.1 Global Top Plasma Therapeutics Players by Revenue (2015-2020)
  • 3.1.2 Global Plasma Therapeutics Revenue Market Share by Players (2015-2020)
• 3.2 Global Plasma Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Plasma Therapeutics Revenue
• 3.4 Global Plasma Therapeutics Market Concentration Ratio
  • 3.4.1 Global Plasma Therapeutics Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Plasma Therapeutics Revenue in 2019
• 3.5 Key Players Plasma Therapeutics Area Served
• 3.6 Key Players Plasma Therapeutics Product Solution and Service
• 3.7 Date of Enter into Plasma Therapeutics Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Plasma Therapeutics Breakdown Data by Type (2015-2026)

• 4.1 Global Plasma Therapeutics Historic Market Size by Type (2015-2020)
• 4.2 Global Plasma Therapeutics Forecasted Market Size by Type (2021-2026)

5 Plasma Therapeutics Breakdown Data by Application (2015-2026)

• 5.1 Global Plasma Therapeutics Historic Market Size by Application (2015-2020)
• 5.2 Global Plasma Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Plasma Therapeutics Market Size (2015-2026)
• 6.2 North America Plasma Therapeutics Market Size by Type (2015-2020)
• 6.3 North America Plasma Therapeutics Market Size by Application (2015-2020)
• 6.4 North America Plasma Therapeutics Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Plasma Therapeutics Market Size (2015-2026)
• 7.2 Europe Plasma Therapeutics Market Size by Type (2015-2020)
• 7.3 Europe Plasma Therapeutics Market Size by Application (2015-2020)
• 7.4 Europe Plasma Therapeutics Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Plasma Therapeutics Market Size (2015-2026)
• 8.2 China Plasma Therapeutics Market Size by Type (2015-2020)
• 8.3 China Plasma Therapeutics Market Size by Application (2015-2020)
• 8.4 China Plasma Therapeutics Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Plasma Therapeutics Market Size (2015-2026)
• 9.2 Japan Plasma Therapeutics Market Size by Type (2015-2020)
• 9.3 Japan Plasma Therapeutics Market Size by Application (2015-2020)
• 9.4 Japan Plasma Therapeutics Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Plasma Therapeutics Market Size (2015-2026)
• 10.2 Southeast Asia Plasma Therapeutics Market Size by Type (2015-2020)
• 10.3 Southeast Asia Plasma Therapeutics Market Size by Application (2015-2020)
• 10.4 Southeast Asia Plasma Therapeutics Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 Baxter
  • 11.1.1 Baxter Company Details
  • 11.1.2 Baxter Business Overview
  • 11.1.3 Baxter Plasma Therapeutics Introduction
  • 11.1.4 Baxter Revenue in Plasma Therapeutics Business (2015-2020))
  • 11.1.5 Baxter Recent Development
• 11.2 CSL Behring
  • 11.2.1 CSL Behring Company Details
  • 11.2.2 CSL Behring Business Overview
  • 11.2.3 CSL Behring Plasma Therapeutics Introduction
  • 11.2.4 CSL Behring Revenue in Plasma Therapeutics Business (2015-2020)
  • 11.2.5 CSL Behring Recent Development
• 11.3 Grifols Therapeutics
  • 11.3.1 Grifols Therapeutics Company Details
  • 11.3.2 Grifols Therapeutics Business Overview
  • 11.3.3 Grifols Therapeutics Plasma Therapeutics Introduction
  • 11.3.4 Grifols Therapeutics Revenue in Plasma Therapeutics Business (2015-2020)
  • 11.3.5 Grifols Therapeutics Recent Development
• 11.4 Octapharma
  • 11.4.1 Octapharma Company Details
  • 11.4.2 Octapharma Business Overview
  • 11.4.3 Octapharma Plasma Therapeutics Introduction
  • 11.4.4 Octapharma Revenue in Plasma Therapeutics Business (2015-2020)
  • 11.4.5 Octapharma Recent Development
• 11.5 Abeona Therapeutics
  • 11.5.1 Abeona Therapeutics Company Details
  • 11.5.2 Abeona Therapeutics Business Overview
  • 11.5.3 Abeona Therapeutics Plasma Therapeutics Introduction
  • 11.5.4 Abeona Therapeutics Revenue in Plasma Therapeutics Business (2015-2020)
  • 11.5.5 Abeona Therapeutics Recent Development
• 11.6 ADMA Biologics
  • 11.6.1 ADMA Biologics Company Details
  • 11.6.2 ADMA Biologics Business Overview
  • 11.6.3 ADMA Biologics Plasma Therapeutics Introduction
  • 11.6.4 ADMA Biologics Revenue in Plasma Therapeutics Business (2015-2020)
  • 11.6.5 ADMA Biologics Recent Development
• 11.7 Amag Pharmaceuticals
  • 11.7.1 Amag Pharmaceuticals Company Details
  • 11.7.2 Amag Pharmaceuticals Business Overview
  • 11.7.3 Amag Pharmaceuticals Plasma Therapeutics Introduction
  • 11.7.4 Amag Pharmaceuticals Revenue in Plasma Therapeutics Business (2015-2020)
  • 11.7.5 Amag Pharmaceuticals Recent Development
• 11.8 Antares Pharma
  • 11.8.1 Antares Pharma Company Details
  • 11.8.2 Antares Pharma Business Overview
  • 11.8.3 Antares Pharma Plasma Therapeutics Introduction
  • 11.8.4 Antares Pharma Revenue in Plasma Therapeutics Business (2015-2020)
  • 11.8.5 Antares Pharma Recent Development
• 11.9 BioDelivery Sciences
  • 11.9.1 BioDelivery Sciences Company Details
  • 11.9.2 BioDelivery Sciences Business Overview
  • 11.9.3 BioDelivery Sciences Plasma Therapeutics Introduction
  • 11.9.4 BioDelivery Sciences Revenue in Plasma Therapeutics Business (2015-2020)
  • 11.9.5 BioDelivery Sciences Recent Development
• 11.10 Bio Products Laboratory
  • 11.10.1 Bio Products Laboratory Company Details
  • 11.10.2 Bio Products Laboratory Business Overview
  • 11.10.3 Bio Products Laboratory Plasma Therapeutics Introduction
  • 11.10.4 Bio Products Laboratory Revenue in Plasma Therapeutics Business (2015-2020)
  • 11.10.5 Bio Products Laboratory Recent Development
• 11.11 Biota Pharmaceuticals
  • 10.11.1 Biota Pharmaceuticals Company Details
  • 10.11.2 Biota Pharmaceuticals Business Overview
  • 10.11.3 Biota Pharmaceuticals Plasma Therapeutics Introduction
  • 10.11.4 Biota Pharmaceuticals Revenue in Plasma Therapeutics Business (2015-2020)
  • 10.11.5 Biota Pharmaceuticals Recent Development
• 11.12 Biotest Pharmaceuticals
  • 10.12.1 Biotest Pharmaceuticals Company Details
  • 10.12.2 Biotest Pharmaceuticals Business Overview
  • 10.12.3 Biotest Pharmaceuticals Plasma Therapeutics Introduction
  • 10.12.4 Biotest Pharmaceuticals Revenue in Plasma Therapeutics Business (2015-2020)
  • 10.12.5 Biotest Pharmaceuticals Recent Development
• 11.13 China Biologic Products
  • 10.13.1 China Biologic Products Company Details
  • 10.13.2 China Biologic Products Business Overview
  • 10.13.3 China Biologic Products Plasma Therapeutics Introduction
  • 10.13.4 China Biologic Products Revenue in Plasma Therapeutics Business (2015-2020)
  • 10.13.5 China Biologic Products Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer

Global Plasma Therapeutics Scope and Market Size
Plasma Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Plasma Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
Human Serum Protein
Plasma-Derived Clotting Factor
Immunoglobulins
High Immunoglobulins

Market segment by Application, split into
Research Laboratories And Institutions
Hospitals
Stand-Alone Blood Banks

Based on regional and country-level analysis, the Plasma Therapeutics market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Plasma Therapeutics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Baxter
CSL Behring
Grifols Therapeutics
Octapharma
Abeona Therapeutics
ADMA Biologics
Amag Pharmaceuticals
Antares Pharma
BioDelivery Sciences
Bio Products Laboratory
Biota Pharmaceuticals
Biotest Pharmaceuticals
China Biologic Products